Treatment of melanoma by passive humoral immunotherapy using antibody drug synergism.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use*; D004357:Drug Synergism; D006041:Goats; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy*; D008558:Melphalan / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D014750:Vincristine; D008558:Melphalan